Leaderboard

En | De
Sie sind hier: Onkologie » Gynäkologische Tumoren 02. Dezember 2020
Suchen
medline.ch
Gynäkologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 11675  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 233494  
   
Development and Validation of a Tai Chi Intervention Protocol for Managing the Fatigue-Sleep Disturbance-Depression Symptom Cluster in Female Breast Cancer Patients.
Complement Ther Med
Yao LQ, Tan JY, Turner C, Wang T.
PMID: 33259909 [PubMed - as supplied by publisher]


Third-line treatment of HER2-positive advanced breast cancer: From no standard to a Pandora's box.
Biochim Biophys Acta Rev Cancer
Tarantino P, Prat A, Cortes J, Cardoso F, Curigliano G.
PMID: 33259892 [PubMed - as supplied by publisher]


Metronomic treatment of vinorelbine with oral capecitabine is tolerable in the randomized Phase 2 study XeNa including patients with HER2 non-amplified metastatic breast cancer.
Acta Oncol
Brems-Eskildsen AS, Linnet S, Danø H, Luczak A, Vestlev PM, Jakobsen EH, Neimann J, Jensen CB, Dongsgaard T, Langkjer ST.
PMID: 33259244 [PubMed - as supplied by publisher]


Comorbidity burden in long-term breast cancer survivors compared with a cohort of population-based controls from the MARIE study.
Cancer
Möhl A, Orban E, Jung AY, Behrens S, Obi N, Chang-Claude J, Becher H.
PMID: 33259052 [PubMed - as supplied by publisher]


Vitamin D receptor (VDR) and metabolizing enzymes CYP27B1 and CYP24A1 in breast cancer.
Mol Biol Rep
Voutsadakis IA.
PMID: 33259013 [PubMed - as supplied by publisher]


Characteristics and prognosis of male breast cancer in Brazil: A cohort study.
Breast J
Thuler LCS, de Aguiar SS, Rapozo D, Bello MA, Bergmann A.
PMID: 33258519 [PubMed - as supplied by publisher]


Osteoporotic Fractures of the Spine, Hip, and Other Locations after Adjuvant Endocrine Therapy with Aromatase Inhibitors in Breast Cancer Patients: a Meta-analysis.
J Korean Med Sci
Lee YK, Lee EG, Kim HY, Lee Y, Lee SM, Suh DC, Yoo JI, Lee S.
PMID: 33258332 [PubMed - in process]


Predictive role of HER2-status on the effectiveness of endocrine adjuvant treatment in postmenopausal breast cancer patients: a population-based cohort study.
Breast Cancer Res Treat
Schiza A, Mauri D, Fredriksson I, Anna-Karin Wennstig, Valachis A.
PMID: 33258078 [PubMed - as supplied by publisher]


Comparative efficacy, safety, and acceptability of single-agent poly (ADP-ribose) polymerase (PARP) inhibitors in BRCA-mutated HER2-negative metastatic or advanced breast cancer: a network meta-analysis.
Aging (Albany NY)
Wang J, Zhang Y, Yuan L, Ren L, Zhang Y, Qi X.
PMID: 33257598 [PubMed - as supplied by publisher]


Unilateral nipple discharge in a man without a palpable mass diagnosed as breast cancer.
BMJ Case Rep
Ramakrishna KN, Durland J, Ramos C, Dhamoon AS.
PMID: 33257364 [PubMed - in process]


Engagement of phytoestrogens in breast cancer suppression: Structural classification and mechanistic approach.
Eur J Med Chem
Tanwar AK, Dhiman N, Kumar A, Jaitak V.
PMID: 33257172 [PubMed - as supplied by publisher]


Fine particulate matter PM2.5 generated by building demolition increases the malignancy of breast cancer MDA-MB-231 cells.
Chemosphere
Cheng CW, Sheu GT, Chou JS, Wang PH, Cheng YC, Lai CY.
PMID: 33257047 [PubMed - as supplied by publisher]


Candidate RNA biomarkers in biofluids for early diagnosis of ovarian cancer: A systematic review.
Gynecol Oncol
Hulstaert E, Morlion A, Levanon K, Vandesompele J, Mestdagh P.
PMID: 33257015 [PubMed - as supplied by publisher]


Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases.
Breast Cancer Res
Leone JP, Emblem KE, Weitz M, Gelman RS, Schneider BP, Freedman RA, Younger J, Pinho MC, Sorensen AG, Gerstner ER, Harris G, Krop IE, Morganstern D, Sohl J, Hu J, Kasparian E, Winer EP, Lin NU.
PMID: 33256829 [PubMed - in process]


Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer.
Cancers (Basel)
Mediratta K, El-Sahli S, D'Costa V, Wang L.
PMID: 33256070 [PubMed]


Doxorubicin-Conjugated Iron Oxide Nanoparticles Synthesized by Laser Pyrolysis: In Vitro Study on Human Breast Cancer Cells.
Polymers (Basel)
Lungu II, Nistorescu S, Badea MA, Petre AM, Udrea AM, Banici AM, Fleac, Andronescu E, Dinischiotu A, Dumitrache F, Staicu A, Bala.
PMID: 33256060 [PubMed]


Characterization of Preoperative, Postsurgical, Acute and Chronic Pain in High Risk Breast Cancer Patients.
J Clin Med
Forget P, Sitter TM, Hollick RJ, Dixon D, van Maanen A, Dekleermaker A, Duhoux FP, De Kock M, Berliere M, On Behalf Of The KBCt Group.
PMID: 33256031 [PubMed]


An Improved, Assay Platform Agnostic, Absolute Single Sample Breast Cancer Subtype Classifier.
Cancers (Basel)
Seo MK, Paik S, Kim S.
PMID: 33255759 [PubMed]


Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial.
Cancers (Basel)
López-Miranda E, Pérez-García JM, Di Cosimo S, Brain E, Ravnik M, Escrivá-de-Romaní S, Vidal M, Gligorov J, Bor, Calabuig L, Sampayo-Cordero M, Malfettone A, Llombart-Cussac A, Suter TM, Cortés J.
PMID: 33255658 [PubMed]


Micronutrients and Breast Cancer Progression: A Systematic Review.
Nutrients
Cuenca-Micó O, Aceves C.
PMID: 33255538 [PubMed - in process]


   
   Artikel 1 - 20 / 233494    Seite 1 von 11675  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Benutzername

Passwort

 

 

Haben Sie Ihr Passwort vergessen?

 

Neu bei My Medline?

Melden Sie sich bei My Medline an!

 

Mehr über My Medline erfahren

mehr >>

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1